Evergreen Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$243K Sell
1,932
-1,110
-36% -$139K 0.01% 914
2025
Q1
$416K Buy
+3,042
New +$416K 0.01% 577
2024
Q4
Sell
-22,354
Closed -$4.33M 1068
2024
Q3
$4.33M Sell
22,354
-1,470
-6% -$285K 0.15% 166
2024
Q2
$5.52M Buy
23,824
+8,424
+55% +$1.95M 0.2% 137
2024
Q1
$3.32M Buy
15,400
+14,441
+1,506% +$3.11M 0.13% 183
2023
Q4
$248K Buy
959
+74
+8% +$19.1K 0.01% 677
2023
Q3
$227K Sell
885
-140
-14% -$36K 0.01% 660
2023
Q2
$292K Buy
1,025
+62
+6% +$17.7K 0.01% 567
2023
Q1
$268K Buy
963
+30
+3% +$8.34K 0.01% 545
2022
Q4
$258K Buy
933
+79
+9% +$21.9K 0.01% 528
2022
Q3
$228K Buy
+854
New +$228K 0.01% 514
2022
Q2
Sell
-1,266
Closed -$267K 574
2022
Q1
$267K Sell
1,266
-205
-14% -$43.2K 0.01% 518
2021
Q4
$353K Sell
1,471
-4,251
-74% -$1.02M 0.01% 433
2021
Q3
$1.62M Buy
5,722
+117
+2% +$33.1K 0.07% 230
2021
Q2
$1.94M Sell
5,605
-1,629
-23% -$564K 0.09% 207
2021
Q1
$2.02M Buy
7,234
+16
+0.2% +$4.48K 0.1% 193
2020
Q4
$1.77M Buy
7,218
+5,885
+441% +$1.44M 0.1% 180
2020
Q3
$378K Buy
1,333
+3
+0.2% +$851 0.03% 298
2020
Q2
$356K Buy
1,330
+142
+12% +$38K 0.03% 282
2020
Q1
$376K Sell
1,188
-538
-31% -$170K 0.04% 253
2019
Q4
$512K Buy
1,726
+161
+10% +$47.8K 0.04% 250
2019
Q3
$364K Buy
1,565
+326
+26% +$75.8K 0.03% 274
2019
Q2
$290K Buy
1,239
+91
+8% +$21.3K 0.03% 321
2019
Q1
$271K Buy
1,148
+41
+4% +$9.68K 0.03% 309
2018
Q4
$333K Sell
1,107
-18
-2% -$5.42K 0.03% 249
2018
Q3
$397K Sell
1,125
-65
-5% -$22.9K 0.04% 244
2018
Q2
$345K Buy
1,190
+401
+51% +$116K 0.03% 242
2018
Q1
$216K Buy
+789
New +$216K 0.02% 327